Jimmy Ruisheng
New type of medicine that is based on personalized medicine and is developing rapidly with the advancement of genomic sequencing technology and the cross-application of bioinformatics and big data science.
Market cap
-
Enterprise valuation
$55—83m (Dealroom.co estimates Mar 2022.)
Suzhou Shi Jiangsu (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | CNY100m | Series B | |
Total Funding | $13.8m |